Skip to main content
. 2023 Jul 25;15(7):3908–3918. doi: 10.21037/jtd-23-923

Table 2. Preoperative clinical characteristics before and after PSM.

Characteristics Primary cohort PSM cohort
Non-PPC (n=314) PPC (n=142) P value Non-PPC (n=135) PPC (n=135) P value
Pre-ALB (g/L) 0.04 0.69
   <45 90 (28.7) 54 (38.0) 44 (32.6) 48 (35.6)
   ≥45 224 (71.3) 88 (62.0) 91 (67.4) 87 (64.4)
FVC 0.001 0.21
   <80% 95 (30.3) 66 (46.5) 49 (36.3) 59 (43.7)
   ≥80% 219 (69.7) 76 (53.5) 86 (63.7) 76 (56.3)
FEV1 0.005 0.58
   <80% 64 (20.4) 46 (32.4) 35 (25.9) 39 (28.9)
   ≥80% 250 (79.6) 96 (67.6) 100 (74.1) 96 (71.1)
FEV1/FVC 0.014 0.41
   <80% 66 (21.0) 45 (31.7) 35 (25.9) 41 (30.4)
   ≥80% 248 (79.0) 97 (68.3) 100 (74.1) 94 (69.6)
DLCO 0.07 0.65
   <80% 51 (16.2) 33 (23.2) 27 (20.0) 31 (23.0)
   ≥80% 263 (83.8) 109 (76.8) 108 (80.0) 104 (77.0)

Data are presented as n (%). PSM, propensity score matching; PPC, postoperative pulmonary complication; Pre-ALB, pre-albumin; FVC, forced vital capacity; FEV1, forced expiratory volume in the first second; DLCO, diffusing capacity of the lungs for carbon monoxide.